Fundraising Fox

Anaconda Biomed

Barcelona, ES · 4 known investors

Anaconda Biomed develops next-generation endovascular access and protection devices. The company serves the medical device market, focusing on vascular intervention procedures.

BiotechHardwareHealthtechMedical Devices

Founders & leadership

TRTrent Reutiman
Trent ReutimaninCEO
HL
Hendrik LambertinVice-President of Clinical & Regulatory Affairs
DI
Dr. Iñaki Galve
JCJordi Cardona
Jordi CardonainFounder

Board

MJ
Maria Jose Alonso

Investors · 4

Asabys PartnersMadrid
Ysios CapitalBarcelona · $5.4M – $21.6M
European Investment BankreportedLuxembourg
Innogest CapitalreportedMilan

In the news

Anaconda Biomed: Innovating Acute Ischemic Stroke treatmenteicscalingclub.eu · Jan 2025Spain: Anaconda Biomed to close venture debt operation of up to €10 million with the EIB to treat acute ischemic stroke (AIS)eib.org · Oct 2021ANACONDA BIOMED S.L. secures €20 Million round of funding - Asabys Partnersasabys.com · Dec 2019Anaconda Biomed Raises €20M Funding Round - FinSMEsfinsmes.com · Dec 2019Anaconda Biomed receives €15 million in financing - Tech.eutech.eu · May 2017Anaconda Biomed raises $17m for next-gen brain thrombectomy device - MassDevicemassdevice.com · May 2017

Frequently asked questions

What does Anaconda Biomed do?
Anaconda Biomed develops next-generation endovascular access and protection devices. The company serves the medical device market, focusing on vascular intervention procedures.
Who are Anaconda Biomed's investors?
Anaconda Biomed's investors include Asabys Partners, Ysios Capital, European Investment Bank, Innogest Capital.
Where is Anaconda Biomed headquartered?
Anaconda Biomed is headquartered in Barcelona, ES.